BI
Investment Director, Venture Fund
Boehringer Ingelheim Venture Fund
Shanghai, CN
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.
The Boehringer Ingelheim Venture Fund Mission is to invest in the development of pioneering science – from idea to proof of concept – which offer the potential to provide significant benefits firstly for patients and also for our business.
Therapeutic and Digital Health Focus
Our sole focus is to search for significant enhancements in patient care through innovative and pioneering science including (but not limited to):
These reflect our interest in platform technologies and the extention of the current therapeutic area focus of Boehringer Ingelheim and demonstrate our commitment to investigate new treatment modalities and technologies, beyond our existing landscape, for the potential future benefit of patients.
Geographical Focus
We recognise that innovation is not restricted by geography and welcome applications from entrepreneurs worldwide.